Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis
- PMID: 2481589
- DOI: 10.1002/eji.1830191216
Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis
Abstract
Thirty-four IgG anti-D human monoclonal antibodies (mAb) derived from 18 donor were assessed for their ability to mediate lysis of D+ red cells by lymphocytes in antibody-dependent cell-mediated cytotoxicity assays. Cell-bound antibody was quantified and the mAb were compared at similar levels of sensitization. The majority (23/31) of IgG1 and all (3/3) IgG3 mAb were ineffective; two donors produced both lytic and non-lytic anti-D mAb. Greater sensitivity was achieved using fluid-phase antibody (as culture supernatants) in the assay than was obtained with pre-sensitized red cells. Minimum levels of 2000 anti-D molecules per cell were required for lysis using pre-sensitized cells. Partial D red cells (DIVa, DVa and DVI) were lysed by three mAb that were lytic with normal D+ cells. There was no relationship between lytic ability and Gm allotype or D epitope specificity of the antibodies. Four mAb to other blood group specificities were tested: two (anti-E and anti-G) were lytic and two (anti-c and anti-Kell) were not lytic. Possible reasons for the heterogeneity of the lytic activity by the mAb are discussed.
Similar articles
-
Synergistic effect of blending IgG1 and IgG3 monoclonal anti-D in promoting the metabolic response of monocytes to sensitized red cells.Immunology. 1989 Aug;67(4):550-2. Immunology. 1989. PMID: 2504663 Free PMC article.
-
Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.Immunology. 1988 Oct;65(2):159-63. Immunology. 1988. PMID: 3192267 Free PMC article.
-
Quantitative influence of antibody and complement coating of red cells on monocyte-mediated cell lysis.J Clin Invest. 1978 May;61(5):1309-19. doi: 10.1172/JCI109048. J Clin Invest. 1978. PMID: 96137 Free PMC article.
-
Functional interactions of aglycosylated monoclonal anti-D with Fc gamma RI+ and Fc gamma RIII+ cells.Immunology. 1991 Apr;72(4):481-5. Immunology. 1991. PMID: 1828055 Free PMC article.
-
Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers.Vox Sang. 2007 Aug;93(2):99-111. doi: 10.1111/j.1423-0410.2007.00945.x. Vox Sang. 2007. PMID: 17683353 Review.
Cited by
-
Clearance of red cells by monoclonal IgG3 anti-D in vivo is affected by the VF polymorphism of Fcgamma RIIIa (CD16).Clin Exp Immunol. 2003 Apr;132(1):81-6. doi: 10.1046/j.1365-2249.2003.02119.x. Clin Exp Immunol. 2003. PMID: 12653840 Free PMC article.
-
Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes.Immunology. 1994 Dec;83(4):624-30. Immunology. 1994. PMID: 7875742 Free PMC article.
-
The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.Immunology. 1992 Jul;76(3):446-51. Immunology. 1992. PMID: 1356095 Free PMC article.
-
Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift.J Clin Invest. 1992 Dec;90(6):2481-90. doi: 10.1172/JCI116140. J Clin Invest. 1992. PMID: 1469099 Free PMC article.
-
Glycosylation and functional activity of anti-D secreted by two human lymphoblastoid cell lines.Cytotechnology. 1994;15(1-3):223-8. doi: 10.1007/BF00762397. Cytotechnology. 1994. PMID: 7765935
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources